STIM 250117 2.50P (STIM250117P2500) Stock Options, News & Quotes

0.05
-0.35-87.50%

15min DelayClose Jan 17 16:00 ET

0.05High0.05Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Muntri George

Jan 14 07:29

CCORF Maintains Neuronetics(STIM.US) With Buy Rating, Maintains Target Price $3

$Neuronetics (STIM.US)$
CCORF analyst William Plovanic maintains $Neuronetics (STIM.US)$ with a buy rating, and maintains the target price at $3.
According to TipRanks data, the analyst has a success rate of 45.4% and a total average return of 1.4% over the past year.

wenlong8810

Jan 13 08:40

$Neuronetics (STIM.US)$ this like going to fly again

Jaguar8

Dec 10, 2024 09:01

NEWS

$Neuronetics (STIM.US)$
Neuronetics and Greenbrook TMS Announce Closing of Transaction
Tuesday, 10th December at 10:00 am
MALVERN, Pa. and TORONTO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTC: GBNHF) ("Greenbrook", and together with Neuronetics, the "Combined Company") today announced that they have successfully completed the previously announced transaction whereby Neuronetics acquired all of the issued and outstanding commo...

Jaguar8

Oct 14, 2024 07:31

NEWS

$Neuronetics (STIM.US)$
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression
Neuronetics, Inc. (NASDAQ: STIM) announced its participation at the American Academy of Child and Adolescent Psychiatry (AACAP) conference in Seattle, WA, from October 14th-19th. The company will present data on the NeuroStar TMS System in an oral presentation at the 'Research Pipeline: New Findings on Therapeutics' session. This presentation will ...

Stock_Drift

Sep 25, 2024 07:33

$Neuronetics (STIM.US)$